Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Background/Aims: The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718). This post-hoc exploratory analysis sought to establish the efficacy and safety of vedolizumab in a subgroup of patients from Asia...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Korean Assoc Study Intestinal Diseases
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/34990/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|